15.30
-0.03 (-0.16%)
| Penutupan Terdahulu | 15.32 |
| Buka | 15.10 |
| Jumlah Dagangan | 256,868 |
| Purata Dagangan (3B) | 463,519 |
| Modal Pasaran | 1,989,359,488 |
| Harga / Pendapatan (P/E TTM) | 12.75 |
| Harga / Pendapatan (P/E Ke hadapan) | 35.21 |
| Harga / Jualan (P/S) | 7.14 |
| Harga / Buku (P/B) | 4.48 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 21 Aug 2024 - 22 Aug 2024 |
| Margin Keuntungan | 60.66% |
| Margin Operasi (TTM) | 16.71% |
| EPS Cair (TTM) | 1.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -61.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -83.20% |
| Nisbah Semasa (MRQ) | 25.42 |
| Aliran Tunai Operasi (OCF TTM) | 119.51 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 98.45 M |
| Pulangan Atas Aset (ROA TTM) | 59.56% |
| Pulangan Atas Ekuiti (ROE TTM) | 75.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | NEUREN FPO NZ [NEU] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.13 |
|
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 13.29% |
| % Dimiliki oleh Institusi | 18.05% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |